Multicenter Studies in Clinical Research: Benefits, Challenges, and Recommendations forEffective Management

Main Article Content

Agustina L. Piccinino
https://orcid.org/0009-0008-4031-8917
Martina C. Ricasoli
https://orcid.org/0009-0006-8478-1984
Mariana Vaena
https://orcid.org/0000-0001-6176-3800
Ana Braslavsky
https://orcid.org/0000-0001-8169-171X
María F. Grande Ratti
https://orcid.org/0000-0001-8622-8230

Abstract

In clinical research, multicenter studies represent a key tool for collecting data from multiple centers, thus increasing the external validity and generalizability of results. The fact that they are conducted simultaneously in several institutions, localities, provinces, or even countries allows for a larger and more diverse sample, which favors representativeness and makes the information applicable to different populations and settings.


This narrative review highlights their advantages and disadvantages and explores in depth the main challenges they entail (ethical, methodological, logistical, and operational). It also analyzes real and relevant examples that illustrate their impact on the generation of robust clinical evidence. Finally, conclusions and practical recommendations for the effective management of these projects are presented, emphasizing the importance of leadership, coordination between centers, the commitment of the research team, and rigorous adherence to ethical and methodological standards.

Downloads

Download data is not yet available.

Article Details

Section

Notes on statistics and research

How to Cite

1.
Piccinino AL, Ricasoli MC, Vaena M, Braslavsky A, Grande Ratti MF. Multicenter Studies in Clinical Research: Benefits, Challenges, and Recommendations forEffective Management. Rev Hosp Ital B.Aires [Internet]. 2026 Jun. 22 [cited 2026 Jul. 7];46(2):e0001293. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1293

References

Das MK. Multicenter Studies: Relevance, Design and Implementation. Indian Pediatr 2022 Jul 15;59(7):571–9. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/34992183 DOI: https://doi.org/10.1007/s13312-022-2561-y

Ramgopal S, Benedetti J, Cotter JM. Performing a Multicenter Retrospective Study. Hosp Pediatr 2025 Feb 1;15(2):e77–82. Disponible en: http://dx.doi.org/10.1542/hpeds.2024-008020 DOI: https://doi.org/10.1542/hpeds.2024-008020

Mahmoud AK, Farina JM, Awad K, Ali NB, Pereyra M, Scalia IG, et al. Lipoprotein(a) and long-term in-stent restenosis after percutaneous coronary intervention. Eur J Prev Cardiol 2024 Nov 11;31(15):1878–87. Disponible en: http://dx.doi.org/10.1093/eurjpc/zwae212 DOI: https://doi.org/10.1093/eurjpc/zwae212

Posadas-Martínez ML, Grande Ratti MF, Burgos MA, Herrera V. Financiamiento en investigación: ¿qué necesito antes de comenzar a buscar una fuente de financiamiento? Parte 1. Rev. Hosp. Ital. B. Aires. 2022;42(2):100-104. http://doi.org/10.51987/revhospitalbaires.v42i2.174 DOI: https://doi.org/10.51987/revhospitalbaires.v42i2.174

Wyss F, Lopez-Santi R, Piskorz D, Gupta S, Munera-Echeverri A, Lopez-Santi P, et al. Immunization and cardiovascular disease in Latin America. The CorVacc study: rationale and design. Arch Cardiol Mex 2025;95(3):144–52. Disponible en: http://dx.doi.org/10.24875/ACM.24000239 DOI: https://doi.org/10.24875/ACME.M25000627

Spina SV, Campos Vieira ML, Herrera CJ, Munera Echeverri AG, Rojo P, Arrioja Salazar AS, et al. Cardiopulmonary Imaging Utilization and Findings among Hospitalized COVID-19 Patients in Latin America: (From “RIMAC: Registry IMAging Cardiopulmonary among Hospitalized COVID-19 Patients in LATAM”). Global Heart 2022 Aug 1;17(1):49. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC9354558/ DOI: https://doi.org/10.5334/gh.1134

Boietti BR, Mirofsky M, Valentini R, Peuchot VA, Cámera LA, Pollán JA, et al. [Descriptive analysis of 4776 patients admitted to medical clinic services for COVID-19. Results of the Argentine Multi-Center Registry - REMA-COVID-19]. Medicina (B Aires) 2021;81(5):703–14. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/34633942

Meinert CL. Toward more definitive clinical trials. Control Clin Trials 1980 Dec;1(3):249–61. Disponible en: http://dx.doi.org/10.1016/0197-2456(80)90005-7 DOI: https://doi.org/10.1016/0197-2456(80)90005-7

Institute of Medicine (US) Council on Health Care Technology, Sox H, Stern S, Owens D, Abrams HL. Problems of Multi-Institutional Studies. In: Assessment of Diagnostic Technology in Health Care: Rationale, Methods, Problems, and Directions: Monograph of the Council on Health Care Technology. National Academies Press (US); 1989. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK235189/

Greene SM, Geiger AM. A review finds that multicenter studies face substantial challenges but strategies exist to achieve Institutional Review Board approval. J Clin Epidemiol 2006 Aug;59(8):784–90. Disponible en: http://dx.doi.org/10.1016/j.jclinepi.2005.11.018 DOI: https://doi.org/10.1016/j.jclinepi.2005.11.018

Kaur N, Kandelman D. “Ethical Considerations For A Multicenter Research”. EC Dental Science 3.2 (2015):501-505. Disponible en: https://www.researchgate.net/publication/286232127_Ethical_Considerations_For_A_Multicenter_Research

DeRenzo E, Singer EA, Moss J. Ethical Considerations When Preparing a Clinical Research Protocol. Academic Press; 2020. 370 p. Disponible en: https://play.google.com/store/books/details?id=oR0tBAAAQBAJ DOI: https://doi.org/10.1016/B978-0-12-386935-7.00004-9

Stiell IG, Perry JJ, Brehaut J, Brown E, Curran JA, Emond M, et al. How to conduct implementation trials and multicentre studies in the emergency department. CJEM 2018 May;20(3):448–52. Disponible en: http://dx.doi.org/10.1017/cem.2017.433 DOI: https://doi.org/10.1017/cem.2017.433

Irving SY, Curley MAQ. Challenges to conducting multicenter clinical research: ten points to consider. AACN Adv Crit Care 2008 Apr-Jun;19(2):164–9. Disponible en: http://dx.doi.org/10.1097/01.AACN.0000318119.67061.0f DOI: https://doi.org/10.1097/01.AACN.0000318119.67061.0f

Most read articles by the same author(s)

1 2 3 > >>